Athersys Inc logo

Athersys Inc Share Price (NASDAQ: ATHX)

▲

-0.01

(-100%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 16 Nov 2023

Check the interactive Athersys Inc Stock chart to analyse performance

Athersys Inc Key Stats

Check Athersys Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.0135
Open
$0.02
Market Capitalization
$521.3K
Today's Volume
$1.1M
Revenue TTM
$146.0K
EBITDA
$-37.4M
Earnings Per Share (EPS)
$-2.58
Dividend Yield
1.87%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1276.02%

Global Institutional Holdings in Athersys Inc

  • Name

    Holdings %

  • Armistice Capital, LLC

    7.27%

  • Vahanian & Associates Financial Planning Inc.

    3.52%

  • BlackRock Inc

    1.68%

  • Vanguard Group Inc

    1.49%

  • Geode Capital Management, LLC

    0.58%

  • Values First Advisors Inc

    0.42%

Analyst Recommendation on Athersys Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Athersys Inc(by analysts ranked 0 to 5 stars)

About Athersys Inc

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.
Organization
Athersys Inc
Employees
24
CEO
Mr. Daniel A. Camardo M.B.A.
Industry
Health Technology

Important FAQs about investing in ATHX Stock from India :

What is Athersys Inc share price today?

Athersys Inc share price today is as on at the close of the market. Athersys Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Athersys Inc share?

Athersys Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Athersys Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Athersys Inc Stock (ATHX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Athersys Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Athersys Inc Shares .

What is the minimum amount required to buy Athersys Inc Stock (ATHX) from India?

Indian investors can start investing in Athersys Inc (ATHX) shares with as little as ₹93.945 or $1 (as of March 24, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹939.45 in Athersys Inc stock (as per the Rupee-Dollar exchange rate as on March 24, 2026). Learn more about fractional shares .

What are the returns that Athersys Inc has given to Indian investors in the last 5 years?

Athersys Inc stock has given 0.0% share price returns and 29.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?